| A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Followin | Phase III | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/I | Phase II | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumita | Phase II | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platin | Phase II | rekrutiert |
| A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With | Phase I / Phase II | rekrutiert |
| A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Muta | Phase III | rekrutiert |
| A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) | Phase III | rekrutiert |
| A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ | — | rekrutiert |
| A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants Wi | Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combi | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants Wi | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Prima | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients U | ohne Phasenangabe | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults Wit | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria | Phase II | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult | Phase III | rekrutiert |
| A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standar | Phase III | rekrutiert |
| A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rit | Phase III | rekrutiert |
| A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Ri | Phase III | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Auricular Acupuncture in Patients With Advanced Cancer: a Randomized Clinical Trial. | ohne Phasenangabe | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Evaluation of a New Platform for Bi-manual Endoscopic Resection in the Rectum and Sigma | ohne Phasenangabe | rekrutiert |
| Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation | Phase II | rekrutiert |
| ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer | ohne Phasenangabe | rekrutiert |
| Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multi | — | rekrutiert |
| EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic | — | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpe | Phase II | rekrutiert |
| Ear Acupressure for Reducing Anxiety and Pain During Heart Surgery | ohne Phasenangabe | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Effect of a Mindfulnes Program "Healthy Under Stress" on Stress: A Prospective Intervention Stud | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With | Phase III | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia | Phase III | rekrutiert |
| Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve In | — | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study | — | rekrutiert |
| Glioblastoma Radiotherapy Using IMRT or Proton Beams | ohne Phasenangabe | rekrutiert |
| Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy | ohne Phasenangabe | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC | Phase II | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease ( | Phase I | rekrutiert |
| Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patie | Phase II | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multifo | ohne Phasenangabe | rekrutiert |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elev | Phase III | rekrutiert |
| MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multi | Phase III | rekrutiert |
| Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL | Phase II | rekrutiert |
| Mind-body Medicine for Patients With Malignant Hematological Diseases | ohne Phasenangabe | rekrutiert |
| Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory M | Phase III | rekrutiert |
| Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection | — | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Observational Study Protocol: LIVER-R | — | rekrutiert |
| One-Month DAPT in CABG Patients | Phase III | rekrutiert |
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced N | Phase II | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor | Phase II | rekrutiert |
| Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Pilot Project on Interdisciplinary Therapy of Obesity | ohne Phasenangabe | rekrutiert |
| Post-Market BTVA Registry | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Product Surveillance Registry | — | rekrutiert |
| Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System | — | rekrutiert |
| Randomization of Single vs Multiple Arterial Grafts | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Cou | Phase IV | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With T | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| SCAD : a Registry of Spontaneous Coronary Artery Dissection | — | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds | ohne Phasenangabe | rekrutiert |
| Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atr | ohne Phasenangabe | rekrutiert |
| Serial Cardiac Magnetic Resonance Imaging (CMR) With Contrast Agents and Biomarker Analysis for | ohne Phasenangabe | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate | — | rekrutiert |
| Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplati | Phase II / Phase III | rekrutiert |
| Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-sm | Phase II / Phase III | rekrutiert |
| Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Wh | Phase III | rekrutiert |
| Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resect | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Rea | — | rekrutiert |
| Tendyne European Experience Registry | — | rekrutiert |
| The "Global Paradise System" Registry | — | rekrutiert |
| The Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block in Patients Undergoing Primary T | ohne Phasenangabe | rekrutiert |
| The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Ob | ohne Phasenangabe | rekrutiert |
| The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Di | Phase III | rekrutiert |
| The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Reg | — | rekrutiert |
| The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable E | ohne Phasenangabe | rekrutiert |
| The German ADPKD Tolvaptan Treatment Registry | — | rekrutiert |
| The ReTAVI Prospective Observational Registry | — | rekrutiert |
| Therapy Optimisation for the Treatment of Hairy Cell Leukemia | Phase II / Phase III | rekrutiert |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in A | — | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therap | Phase IV | rekrutiert |
| Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Seco | Phase III | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Rela | Phase I / Phase II | rekrutiert |
| Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID | ohne Phasenangabe | rekrutiert |